• Corpus ID: 150370987

A Comparative Study between Topical 5 % Minoxidil and Topical “ Redensyl , Capixyl , and Procapil ” Combination in Men with Androgenetic Alopecia

  title={A Comparative Study between Topical 5 \% Minoxidil and Topical “ Redensyl , Capixyl , and Procapil ” Combination in Men with Androgenetic Alopecia},
  author={Nezih Karaca and Nebahat Demet Akpolat},
Objective: Androgenetic Alopecia (AGA) is one of the three most common forms of noncicatricial alopecia characterized by hair loss in both men and women. It occurs in 50% of men above in their sixth decade. Currently, two effective treatments for AGA are used in men: topical minoxidil and oral finasteride. However, although clinical studies have shown that minoxidil and finasteride have positive therapeutic outcomes, their use can have certain side-effects. In this study, we aimed to compare… 
2 Citations

Figures and Tables from this paper

Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: A Comparative Controlled Study

Scalp injection with mesotherapy (LC cell hair essence) helps in anchoring hair follicles and might have good therapeutic efficacy and lower side effects than Botox in the treatment of androgenetic

Managing patterned hair loss – a hair raising task!

This short review has attempted to condense existing information into a ready reference on patterned hair loss, moving well beyond the FDA-approved modalities - topical minoxidil and oral finasteride.



An Open, Randomized, Comparative Study of Oral Finasteride and 5% Topical Minoxidil in Male Androgenetic Alopecia

Both drugs were effective and safe in the treatment of mild to severe AGA, although oral finasteride treatment was more effective (p < 0.05); side effects were all mild, and there was no need to stop the treatment.

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

Data from a patient questionnaire demonstrated that 5% topical minoxidil helped improve patients' psychosocial perceptions of hair loss in men with androgenetic alopecia as well as boosting hair regrowth in this 48-week trial.

Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.

  • C. Tanglertsampan
  • Medicine
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • 2012
Although change of hair counts was not statistically different between two groups, global photographic assessment showed significantly greater improvement in the MFX group than the MNX group, suggesting that MFX may be a safe and effective treatment option.

Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men

It is inferred that the therapeutic efficacy is enhanced by combining the two drugs acting on different aetiological aspects of AGA by combining finasteride alone or in combination with minoxidil or ketoconazole.

Use of topical minoxidil in the treatment of male pattern baldness.

  • R. Savin
  • Medicine
    Journal of the American Academy of Dermatology
  • 1987

Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.

Hair weight increased to a larger extent than hair count, implying that factors other than the number of hairs, such as increased growth rate (length and thickness of hairs) contribute to the beneficial effects of finasteride in treated men.

Finasteride: a review of its use in male pattern hair loss.

Oral finasteride promotes scalp hair growth and prevents further hair loss in a significant proportion of men with male pattern hair loss, and is a new approach to the management of this condition, for which treatment options are few.

A new strategy to modulate alopecia using a combination of two specific and unique ingredients.

Investigation of the potential mechanisms involved in the positive effects of the test product on hair growth pointed at inhibition of 5-α-reductase activity, reduction of inflammatory reactions, and stimulation of ECM protein synthesis in the vicinity of the hair follicle.

Minoxidil use in dermatology, side effects and recent patents.

The mechanism of action of Minoxidil, a vasodilator medication known for its ability to slow or stop hair loss and promote hair regrowth, and use in dermatology and some patents related to alternative treatment of allergic reactions due to its use are described.